Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.72
Delayed Data
As of Feb 27
 -0.05 / -0.46%
Today’s Change
4.13
Today|||52-Week Range
12.00
-5.13%
Year-to-Date

Today’s Trading

Previous close10.77
Today’s open10.77
Day’s range10.52 - 10.80
Volume1,161,618
Average volume (3 months)1,675,506
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+32.83%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.03+0.43%
EBSEmergent BioSolution...-0.40-1.32%
SAGESAGE Therapeutics In...+0.46+1.07%
ARRYArray Biopharma Inc-0.15-1.85%
Data as of 4:02pm ET, 02/27/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account